Temasek Holdings
ABBV icon

Temasek Holdings’s AbbVie ABBV Stock Holding History

Temasek Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-67,969
Closed -$15.7M – 142
2025
Q3 		$15.7M Buy
67,969
+25,496
+60% +$5.19M 0.05% 100
2025
Q2 		$7.88M Hold
42,473
– – 0.03% 117
2025
Q1 		$8.9M Hold
42,473
– – 0.04% 101
2024
Q4 		$7.55M Sell
42,473
-191,025
-82% -$35.1M 0.03% 99
2024
Q3 		$46.1M Buy
233,498
+41,093
+21% +$7.67M 0.19% 55
2024
Q2 		$33M Buy
192,405
+83,174
+76% +$13.8M 0.15% 57
2024
Q1 		$19.9M Buy
109,231
+73,466
+205% +$12.7M 0.11% 53
2023
Q4 		$5.54M Buy
35,765
+18,239
+104% +$2.66M 0.03% 64
2023
Q3 		$2.61M Buy
+17,526
New +$2.57M 0.02% 65

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Temasek Holdings's ABBV Position: Q4 2025 in Review

Temasek Holdings sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 67,969 shares — an estimated $15.7M sold.

Temasek Holdings first reported a position in ABBV in Q3 2023 and held it in 9 quarters. The position peaked at $46.1M in Q3 2024. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Temasek Holdings reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • Temasek Holdings sold 67,969 AbbVie shares in Q4 2025, an estimated $15.7M.
  • Temasek Holdings first reported a position in AbbVie in Q3 2023 and held it in 9 quarters.
  • Temasek Holdings's AbbVie position peaked at $46.1M in Q3 2024.
  • 4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Temasek Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.